Private hospital operator Life Healthcare has made changes to its leadership structure after the disposal of the Alliance Medical Group (AMG) and the executive committees of Life Healthcare and AMG have been combined and reconstituted.
“This has been done to consolidate capabilities and experience of the team to ensure the effective delivery of the Life Healthcare strategy,” the company said on Thursday.
The reconstituted executive committee will continue to be led by Peter Wharton-Hood as the CEO.
Pieter van der Westhuizen will remain as CFO, but will also assume responsibility for the IT and cyber portfolios.
Adam Pyle moves from the role of CEO Southern Africa into the new position of chief strategy and growth officer where he will take responsibility for the critical focus on Southern Africa growth opportunities. These include renal dialysis, diagnostic imaging, nuclear medicine and oncology.
Pyle’s portfolio will also include stakeholder relations, new products, marketing and communication as well as investor relations. He will also co-ordinate Life Healthcare’s strategy.
The chief strategy and growth officer is a critical role in delivering on the company's future growth strategy, it said.
Craig Koekemoer, who previously held the position of business operations executive SA, will take on the new role of COO.
“These important changes ensure a smooth transition, retain key industry experience and will enable Life Healthcare to deliver on its strategy going forward,” it said.
Life Healthcare recently distributed the proceeds of the sale of its interest in UK-based AMG to shareholders by way of a special dividend of R6 per share.
The company’s shares were down 2.46% at R10.71 by midmorning on the JSE.
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.